Industry News

NanoViricides is expanding in West Haven, Conn., with the acquisition of an 18,000-sf facility. The building will house laboratories and a cGMP pilot plant for production of nanoviricide pharmaceutical candidates for clinical trials. NanoViricides is engaged in creating anti-viral drugs for H1N1, H5N1, seasonal influenza, hepatitis, rabies, Dengue fever, and Ebola. 

Analog Devices will construct a $68.3 million research and development facility in Raheen, Ireland. Built adjacent to Analog's existing manufacturing center, the two-story, 140,000-sf facility will house engineering labs, offices, and meeting rooms to accommodate 100 employees. Analog Devices is a semiconductor manufacturer based in Boston.

The University of Maryland will build a world-class teaching and learning center on its College Park campus. The $63 million, 47,900-sf classroom facility is expected to open in 2016.

Fraunhofer USA's Center for Molecular Biotechnology was awarded $1.5 million in September of 2011 by the Defense Threat Reduction Agency. Fraunhofer will provide the United States government with a sustainable source of reagents for advancing critical research aimed at developing countermeasures to combat potentially devastating biological pathogens. These reagents will also be valuable for surveillance and diagnostic purposes.

Bridgewater State University opened the first phase of the newly expanded and renovated Science and Mathematics Center in September of 2011. Designed by Payette, the five-story, 168,000-sf facility will provide space for the departments of biology, chemistry, earth science, geography, physics, math, and computer science. The project team includes R.G.